Neurocognitive functioning and psychological outcomes in advanced cancer survivors treated with immune checkpoint blockade: A prospective longitudinal study.
Cancer · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
Advanced cancerNeurocognitive FunctioningsurvivorshipImmune Checkpoint BlockadePatient‐reported OutcomesFear Of Cancer RecurrenceCancer‐Related Cognitive ImpairmentHumansFemaleMaleLongitudinal StudiesProspective StudiesMiddle AgedImmune Checkpoint InhibitorsCancer SurvivorsAgedQuality of LifeNeoplasmsNeuropsychological TestsPatient Reported Outcome MeasuresAdultDepressionFearCognitionCase-Control Studiesadvanced cancercancer‐related cognitive impairmentfear of cancer recurrenceimmune checkpoint blockadeneurocognitive functioningpatient‐reported outcomes
Come citare questo studio
Nathalie Vanlaer, Iris Dirven, Cleo Bertels, Cristina Delgado-Alonso, Jordi A Matias-Guiu, Bart Neyns, Anne Rogiers. (2026). Neurocognitive functioning and psychological outcomes in advanced cancer survivors treated with immune checkpoint blockade: A prospective longitudinal study.. Cancer. DOI: 10.1002/cncr.70668
Consulta la pubblicazione originale ↗